2010
DOI: 10.1007/s00228-009-0776-7
|View full text |Cite
|
Sign up to set email alerts
|

Possible hepatotoxic effect of rooibos tea: a case report

Abstract: International audienc

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
14
1

Year Published

2011
2011
2023
2023

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 26 publications
(15 citation statements)
references
References 5 publications
0
14
1
Order By: Relevance
“…This case study is the first report suggesting that rooibos may have adverse hepatic effects. The authors stated that in spite of rooibos's excellent safety record, further studies are recommended to resolve this question (Sinisalo et al, 2010). In the current study, average increases in some of the hepatic enzymes were noted, but may not be of clinical importance, as the values are still within the normal reference ranges, however this could be indicative that some of the volunteers had anomalous reactions to rooibos.…”
Section: Discussioncontrasting
confidence: 60%
See 1 more Smart Citation
“…This case study is the first report suggesting that rooibos may have adverse hepatic effects. The authors stated that in spite of rooibos's excellent safety record, further studies are recommended to resolve this question (Sinisalo et al, 2010). In the current study, average increases in some of the hepatic enzymes were noted, but may not be of clinical importance, as the values are still within the normal reference ranges, however this could be indicative that some of the volunteers had anomalous reactions to rooibos.…”
Section: Discussioncontrasting
confidence: 60%
“…These results are in line with the findings obtained from two previous human studies (Hesseling et al, 1979;Breet et al, 2005) and an experimental animal study (Marnewick et al, 2003) and serves to establish the safety of short term consumption of rooibos. Recently, a case study was reported by Sinisalo et al (2010) that describe a 42-year-old woman who had been diagnosed with a low-grade B-cell malignancy, Waldenstrom's macroglobulinemia, in 2004. She exhibited elevated plasma levels of ALT, GGT and ALP on a clinical visit.…”
Section: Discussionmentioning
confidence: 96%
“…Although anecdotal evidence suggests that consumption of rooibos is generally regarded as safe, recently, two case studies have suggested the po-tential for herb-drug hepatotoxicity. In the first case [165], a 42year-old woman treated for a low-grade B-cell malignancy with rituximab and maintained on prednisolone and co-trimoxazole daily, presented with elevated liver enzymes. She was advised to stop drinking rooibos flavoured with small amounts of strawberry, chamomile, and petals of daisy and discontinue her prophylactic antibiotic (co-trimoxazole).…”
Section: Herb-drug Interactionsmentioning
confidence: 99%
“…This observation from our study becomes all the more important, especially with recent cases of possible adverse hepatic effects of rooibos. Sinisalo et al (2010) reported a case of a 42-year-old patient diagnosed with a low grade B-cell malignancy, Waldenstrom's macroglobulinemia, six years earlier, who temporarily experienced elevated liver enzymes after consuming relatively large amount of rooibos. The study however re-affirms the excellent safety record of rooibos and concluded that contamination of the rooibos herbal tea by some hepatotoxic compound, genetic predisposition and/or diseased state of the patient may be responsible for the effect.…”
Section: Discussionmentioning
confidence: 99%